# A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults

> **NCT01687985** · PHASE2 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 81 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** BLI801 laxative - low dose
- **DRUG:** BLI801 laxative - high dose

## Key facts

- **NCT ID:** NCT01687985
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687985, "A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01687985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*